Acquisition by Jeffrey Peters of 26250 shares of MacroGenics subject to Rule 16b-3

MGNX Stock  USD 3.48  0.02  0.57%   
Slightly above 67% of MacroGenics' investor base is looking to short. The analysis of the overall investor sentiment regarding MacroGenics suggests that many traders are alarmed. MacroGenics' investing sentiment can be driven by a variety of factors including economic data, MacroGenics' earnings reports, geopolitical events, and overall market trends.
  
Filed transaction by MacroGenics Officer: Senior Vp And General Counsel. Grant, award or other acquisition pursuant to Rule 16b-3(d)

Read at macroaxis.com
MacroGenics insider trading alert for acquisition of common stock by Jeffrey Peters, Officer: Senior Vp And General Counsel, on 21st of July 2024. This event was filed by MacroGenics with SEC on 2024-02-22. Statement of changes in beneficial ownership - SEC Form 4. Jeffrey Peters currently serves as vice president general counsel of MacroGenics

Cash Flow Correlation

MacroGenics' cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the MacroGenics' relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.
Click cells to compare fundamentals

MacroGenics Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards MacroGenics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

MacroGenics Fundamental Analysis

We analyze MacroGenics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MacroGenics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MacroGenics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Price To Book

Price To Book Comparative Analysis

MacroGenics is currently under evaluation in price to book category among its peers. Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.

MacroGenics Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with MacroGenics stock to make a market-neutral strategy. Peer analysis of MacroGenics could also be used in its relative valuation, which is a method of valuing MacroGenics by comparing valuation metrics with similar companies.

Peers

MacroGenics Related Equities

ZNTLZentalis Pharmaceuticals   11.14   
0%
100.0%
GLUEMonte Rosa   8.40   
0%
75.0%
INZYInozyme Pharma   5.84   
0%
52.0%
KZRKezar Life   2.21   
0%
19.0%
TYRATyra Biosciences   1.72   
0%
15.0%
MLYSMineralys Therapeutics,   0.91   
0%
8.0%
ANTXAN2 Therapeutics   1.39   
12.0%
0%
MOLNMolecular Partners   1.92   
17.0%
0%
DAWNDay One   2.04   
18.0%
0%
CGEMCullinan Oncology   2.76   
24.0%
0%
PHVSPharvaris   2.78   
24.0%
0%
IPSCCentury Therapeutics   3.29   
29.0%
0%
PTGXProtagonist Therapeutics   3.71   
33.0%
0%
PEPGPepGen   4.03   
36.0%
0%
NKTXNkarta   4.26   
38.0%
0%
CCCCC4 Therapeutics   5.20   
46.0%
0%
PMVPPmv Pharmaceuticals   5.36   
48.0%
0%
EWTXEdgewise Therapeutics   7.21   
64.0%
0%
SNDXSyndax Pharmaceuticals   8.52   
76.0%
0%

Additional Tools for MacroGenics Stock Analysis

When running MacroGenics' price analysis, check to measure MacroGenics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MacroGenics is operating at the current time. Most of MacroGenics' value examination focuses on studying past and present price action to predict the probability of MacroGenics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MacroGenics' price. Additionally, you may evaluate how the addition of MacroGenics to your portfolios can decrease your overall portfolio volatility.